To Test 2 Doses of GSK Biologicals’ Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants in co-Administration With Specific Childhood Vaccines

This study has been completed.

Study NCT00140686 Information provided by GlaxoSmithKline

First Received: August 31, 2005 Last Updated: February 12, 2007 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given